Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Long Term Provisions

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Long Term Provisions History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Long Term Provisions ₹249 Cr₹155 Cr₹123 Cr₹98 Cr₹80 Cr

What is the latest Long Term Provisions ratio of MANKIND PHARMA ?

The latest Long Term Provisions ratio of MANKIND PHARMA is ₹249 Cr based on Mar2026 Consolidated results.
Year Long Term Provisions
Mar2026₹249 Cr
Mar2025₹155 Cr
Mar2024₹123 Cr
Mar2023₹98 Cr
Mar2022₹80 Cr

How is Long Term Provisions of MANKIND PHARMA Trending?

Years Long Term Provisions % Change
Mar2026 ₹249 Cr
60.36
Mar2025 ₹155 Cr
25.94
Mar2024 ₹123 Cr
25.78
Mar2023 ₹98 Cr
22.36
Mar2022 ₹80 Cr -

Compare Long Term Provisions of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹102,217.5 Cr 6.8% 4.6% -6.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,597.0 Cr 1% -3.3% 13.1% Stock Analytics
DIVIS LABORATORIES ₹255,195.0 Cr 2.6% 10.8% 57.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,712.0 Cr 2.7% 0.3% 39.6% Stock Analytics
CIPLA ₹113,423.0 Cr 2.4% -1.1% -12.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,195.0 Cr 2.5% 0.8% -8.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

6.8%

4.6%

-6.7%

SENSEX

-1%

-4.9%

-11%


You may also like the below Video Courses